Research ArticleArticle
Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease
Jessica A. Walsh, Marilyn T. Wan, Christine Willinger, M. Elaine Husni, Jose U. Scher, Soumya M. Reddy and Alexis Ogdie
The Journal of Rheumatology October 2019, jrheum.190219; DOI: https://doi.org/10.3899/jrheum.190219
Jessica A. Walsh
Supported by the US National Institutes of Health/ US National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR072363). Dr. Walsh has received consulting fees or research grants from AbbVie and Pfizer. Dr. Husni is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Scher has received consulting fees from Novartis. Dr. Ogdie has received grants from Amgen and Pfizer to the trustees of the University of Pennsylvania. J.A. Walsh, MD, MBA, A. Ogdie, MD, MSCE, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; M.T. Wan, MBChB, MPH, Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; C. Willinger, BS, University of Pennsylvania, Philadelphia, Pennsylvania; M.E. Husni, MD, MPH, Cleveland Clinic, Cleveland, Ohio; J.U. Scher, MD5, S.M. Reddy MD5, New York University School of Medicine, New York, New York, USA. Address correspondence to Dr. A. Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alexis.ogdie@uphs.upenn.edu. Accepted for publication September 18, 2019.
Marilyn T. Wan
Supported by the US National Institutes of Health/ US National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR072363). Dr. Walsh has received consulting fees or research grants from AbbVie and Pfizer. Dr. Husni is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Scher has received consulting fees from Novartis. Dr. Ogdie has received grants from Amgen and Pfizer to the trustees of the University of Pennsylvania. J.A. Walsh, MD, MBA, A. Ogdie, MD, MSCE, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; M.T. Wan, MBChB, MPH, Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; C. Willinger, BS, University of Pennsylvania, Philadelphia, Pennsylvania; M.E. Husni, MD, MPH, Cleveland Clinic, Cleveland, Ohio; J.U. Scher, MD5, S.M. Reddy MD5, New York University School of Medicine, New York, New York, USA. Address correspondence to Dr. A. Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alexis.ogdie@uphs.upenn.edu. Accepted for publication September 18, 2019.
Christine Willinger
Supported by the US National Institutes of Health/ US National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR072363). Dr. Walsh has received consulting fees or research grants from AbbVie and Pfizer. Dr. Husni is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Scher has received consulting fees from Novartis. Dr. Ogdie has received grants from Amgen and Pfizer to the trustees of the University of Pennsylvania. J.A. Walsh, MD, MBA, A. Ogdie, MD, MSCE, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; M.T. Wan, MBChB, MPH, Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; C. Willinger, BS, University of Pennsylvania, Philadelphia, Pennsylvania; M.E. Husni, MD, MPH, Cleveland Clinic, Cleveland, Ohio; J.U. Scher, MD5, S.M. Reddy MD5, New York University School of Medicine, New York, New York, USA. Address correspondence to Dr. A. Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alexis.ogdie@uphs.upenn.edu. Accepted for publication September 18, 2019.
M. Elaine Husni
Supported by the US National Institutes of Health/ US National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR072363). Dr. Walsh has received consulting fees or research grants from AbbVie and Pfizer. Dr. Husni is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Scher has received consulting fees from Novartis. Dr. Ogdie has received grants from Amgen and Pfizer to the trustees of the University of Pennsylvania. J.A. Walsh, MD, MBA, A. Ogdie, MD, MSCE, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; M.T. Wan, MBChB, MPH, Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; C. Willinger, BS, University of Pennsylvania, Philadelphia, Pennsylvania; M.E. Husni, MD, MPH, Cleveland Clinic, Cleveland, Ohio; J.U. Scher, MD5, S.M. Reddy MD5, New York University School of Medicine, New York, New York, USA. Address correspondence to Dr. A. Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alexis.ogdie@uphs.upenn.edu. Accepted for publication September 18, 2019.
Jose U. Scher
Supported by the US National Institutes of Health/ US National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR072363). Dr. Walsh has received consulting fees or research grants from AbbVie and Pfizer. Dr. Husni is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Scher has received consulting fees from Novartis. Dr. Ogdie has received grants from Amgen and Pfizer to the trustees of the University of Pennsylvania. J.A. Walsh, MD, MBA, A. Ogdie, MD, MSCE, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; M.T. Wan, MBChB, MPH, Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; C. Willinger, BS, University of Pennsylvania, Philadelphia, Pennsylvania; M.E. Husni, MD, MPH, Cleveland Clinic, Cleveland, Ohio; J.U. Scher, MD5, S.M. Reddy MD5, New York University School of Medicine, New York, New York, USA. Address correspondence to Dr. A. Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alexis.ogdie@uphs.upenn.edu. Accepted for publication September 18, 2019.
Soumya M. Reddy
Supported by the US National Institutes of Health/ US National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR072363). Dr. Walsh has received consulting fees or research grants from AbbVie and Pfizer. Dr. Husni is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Scher has received consulting fees from Novartis. Dr. Ogdie has received grants from Amgen and Pfizer to the trustees of the University of Pennsylvania. J.A. Walsh, MD, MBA, A. Ogdie, MD, MSCE, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; M.T. Wan, MBChB, MPH, Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; C. Willinger, BS, University of Pennsylvania, Philadelphia, Pennsylvania; M.E. Husni, MD, MPH, Cleveland Clinic, Cleveland, Ohio; J.U. Scher, MD5, S.M. Reddy MD5, New York University School of Medicine, New York, New York, USA. Address correspondence to Dr. A. Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alexis.ogdie@uphs.upenn.edu. Accepted for publication September 18, 2019.
Alexis Ogdie
Supported by the US National Institutes of Health/ US National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR072363). Dr. Walsh has received consulting fees or research grants from AbbVie and Pfizer. Dr. Husni is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Scher has received consulting fees from Novartis. Dr. Ogdie has received grants from Amgen and Pfizer to the trustees of the University of Pennsylvania. J.A. Walsh, MD, MBA, A. Ogdie, MD, MSCE, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; M.T. Wan, MBChB, MPH, Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; C. Willinger, BS, University of Pennsylvania, Philadelphia, Pennsylvania; M.E. Husni, MD, MPH, Cleveland Clinic, Cleveland, Ohio; J.U. Scher, MD5, S.M. Reddy MD5, New York University School of Medicine, New York, New York, USA. Address correspondence to Dr. A. Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alexis.ogdie@uphs.upenn.edu. Accepted for publication September 18, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease
Jessica A. Walsh, Marilyn T. Wan, Christine Willinger, M. Elaine Husni, Jose U. Scher, Soumya M. Reddy, Alexis Ogdie
The Journal of Rheumatology Oct 2019, jrheum.190219; DOI: 10.3899/jrheum.190219
Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease
Jessica A. Walsh, Marilyn T. Wan, Christine Willinger, M. Elaine Husni, Jose U. Scher, Soumya M. Reddy, Alexis Ogdie
The Journal of Rheumatology Oct 2019, jrheum.190219; DOI: 10.3899/jrheum.190219